INKA App Clinical Study: Overactive Bladder Patient Outcomes in Germany

A 12-week randomized controlled trial in Germany assessed the INKA mobile health app for therapy-refractory overactive bladder and mixed incontinence. The dataset likely contains patient outcomes from 251 recruited participants across 35 study sites, with results from 111 evaluable patients. The study was authored by L. Schramm and published on figshare in 2026.

Use Cases

• Analyzing the impact of a digital therapy app on micturition frequency based on the reported 24-hour frequency changes.
• Comparing quality of life improvements between intervention and control groups based on ICIQ-OABqol questionnaire scores.
• Investigating treatment efficacy in patient subgroups based on reported outcomes for female users and those with heightened symptom severity.
• Evaluating patient engagement with digital health tools based on the reported daily app usage rate.

Strengths

• Includes results from a randomized controlled trial with 251 recruited patients.
• Reports specific, clinically meaningful outcomes such as a mean reduction of -1.02 micturitions per 24h in the intervention group.
• Data collection followed a structured protocol with assessments at baseline, 4 weeks, and 12 weeks.
• Study was registered with the German Clinical Trials Register (DRKS ID 00029329).

Limitations

• Row count and column-level documentation are unknown, limiting suitability assessment.
• The dataset is very small (35.2 KB), suggesting it may contain summary results rather than raw patient-level data.
• The description metadata is limited; actual data structure and quality require manual inspection after download.

Provenance

Source

figshare, author L. Schramm.

Collection Method

Data collected from a two-arm, randomized, unblinded, controlled, multicentre clinical study.

Time Range

Study duration was 12 weeks.

Freshness

Last updated 2026-04-10 06:00:11.

Geography

Data was collected at 35 study sites in Germany.